Trimetaz (Trimetazidine Hydrochloride)

Trimetazidine is a medication primarily used to treat angina pectoris, a type of chest pain caused by reduced blood flow to the heart muscle. It works by improving the efficiency of the heart muscle's energy metabolism, helping it function better under conditions of reduced oxygen supply, such as during angina attacks. Trimetazidine is classified as a metabolic agent and is thought to work by inhibiting the enzyme fatty acid oxidation, thus shifting the heart's energy production towards more efficient use of glucose. This helps reduce the workload on the heart and improve its ability to function effectively, leading to a decrease in angina symptoms. Trimetazidine is typically taken orally and is generally well-tolerated, but it may cause side effects such as nausea, dizziness, and headache. Therefore, it's important to use trimetazidine under the guidance of a healthcare professional and to follow the recommended dosage and monitoring. Additionally, it should not be used in certain populations, such as those with severe kidney or liver disease.